Telemedicine market in India to reach USD 5.5 billion by 2025: EY-IPA study

By: |
September 8, 2020 4:51 PM

The Indian healthcare industry needs to shift from traditional in-person doctor-patient interaction to digitally-enabled remote consultations, according to an EY-IPA study which said the domestic telemedicine market will reach USD 5.5 billion by 2025.

On August 10, the national telemedicine service, e- Sanjeevani, completed more than 1,50,000 tele-consultations.There is an immediate need for a strong regulatory framework in the interest of pa.tients and consumers

The Indian healthcare industry needs to shift from traditional in-person doctor-patient interaction to digitally-enabled remote consultations, according to an EY-IPA study which said the domestic telemedicine market will reach USD 5.5 billion by 2025. “15-20 per cent of the healthcare ecosystem is expected to shift to virtual care, across triaging, consults, remote monitoring, home health, etc, the study, ‘healthcare goes mobile: Evolution of teleconsultation and e-pharmacy in new Normal’, said.

However, the rapid growth driven by increased digitisation will raise challenges related to patient’s data privacy and prescription substitution. Thus, there is an immediate need for a strong regulatory framework in the interest of patients and consumers, it added. “The telemedicine market in India is expected to grow at a compound annual growth rate (CAGR) of 31 per cent for the period 2020-25 and reach USD 5.5 billion”, the study said. Virtual care consists of teleconsult, telepathology, teleradiology and e-pharmacy and is experiencing an encouraging stimulus in India due to the pandemic, it added. This stimulus has the potential to make teleconsultation and e-pharmacy account for around 95 per cent of the telemedicine market by 2025 which amounts to USD 5.2 billion, the study said.

As per the study, India’s e-pharmacy market is projected to reach 10-12 per cent of the overall pharmaceutical sales in the next five years driven by strong regulations, increased funding and creation of digital infrastructure, it added. “As the COVID-19 pandemic throws unprecedented challenges, consumer behaviour and patterns are changing dramatically. With the new norms of ‘social distancing’, traditional ways of in-person doctor-patient interaction are being digitally enabled by remote consultations,” Indian Pharmaceutical Alliance (IPA) Secretary-General Sudarshan Jain said. While the technology will be a great enabler, evolving regulation should guard areas of patient privacy which is fundamental in relation to healthcare, he added.

EY India Life Sciences – Partner & Leader Sriram Shrinivasan said: “With the current levels of adoption by the patients and doctors along with emerging technologies and ecosystem, India is well poised to grow the digital health ecosystem.” For wider acceptance and usage, there is a need for a robust regulatory and governance framework that provides the right support for growth, he added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Bars in Andhra Pradesh to be re-opened from September 19
2Coronavirus vaccine: EU seals second coronavirus vaccine deal
3Effective COVID-19 vaccine likely to be available by first quarter of 2021: Choubey